Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-01-07 @ 7:07 AM
Study NCT ID:
NCT02230995
Status:
COMPLETED
Last Update Posted:
2017-03-09
First Post:
2014-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-29
First Submit QC Date:
None
Study First Post Date:
2014-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-19
Results First Submit QC Date:
None
Results First Post Date:
2017-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-19
Last Update Post Date:
2017-03-09
Last Update Post Date Type:
ACTUAL